Green Park & Golf Ventures
Venture capitalDallas · Pre-Seed–Growth · 10 people tracked
Investment thesis
Green Park & Golf Ventures pursues investment opportunities in medical-related startups that can deliver above-market returns. Building on the founders' operational track record from MedicalEdge and PhyServe, the firm seeks disruptive, fresh ideas addressing large markets with high barriers to entry, backed by passionate, seasoned management teams of two or more people. It values companies that treat others with compassion and dignity and that align incentives across owners, management and employees. Typical investments range from $500,000 to $2,000,000, deployed as either start-up or growth capital, with the firm's level of involvement varying based on the entrepreneur's needs and the company's stage.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from the firm's website
What they invest in
from 48 of 60 portfolio companiesHealthtech ×29Biotech ×18Medical Devices ×17AI & Machine Learning ×9Digital Health ×9SaaS ×8Hardware ×6Deep Tech ×5
HQs:United States×30Sweden×1
Who they back
founder profiles across 17 portfolio companiesFounding team size:solo founder×102 founders×33 founders×34+ founders×1
Investments · 60 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 22019 · 22018 · 22017 · 22016 · 110 dated
Lantern Pharma is a pharmaceutical biotechnology company that applies machine learning and AI to oncology drug development, using data-driven hypothesis testing with in vitro and in vivo models.
AI & Machine LearningBiotechHealthtechDallas, US
Arunkumar Asaithambi(Director)David R. Margrave(Chief Financial Officer, Secretary)Panna Sharma(Chief Executive Officer, President)Kishor G. Bhatia(Chief Scientific Officer)David Keyser(Director)John Fucci(Director)
Co-investorsHealth Wildcatters
Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.
BiotechHealthtechMedical DevicesAustin, US
Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)Mike Ciesla(Executive Officer)Badrul Chowdhury(Executive Officer)Santosh J. Vetticaden(Executive Officer)Gregory D. Gorgas(Executive Officer)Patrick Keran(Executive Officer)
Co-investorsBain Capital Life SciencesCentral Texas Angel NetworkKeiretsu ForumMoore Venture PartnersNew Enterprise Associates (NEA)
Dallas, US
Lance M Hardenburg(Manager of the General Partner of Issuer)Carl D Soderstrom(Manager of the General Partner of Issuer)inJason L Signor(Manager of the General Partner of Issuer)
Board seatCarl Soderstrom· per SEC Form D · $4M raise · filed Jan 2018
Dallas, US
Carl D Soderstrom(Manager of the General Partner of Issuer)inLance M Hardenburg(Manager of the General Partner of Issuer)Jason L Signor(Manager of the General Partner of Issuer)
Board seatCarl Soderstrom· per SEC Form D · $3.1M raise · filed Oct 2017
Dallas, US
Carl D Soderstrom(Manager of the General Partner of Issuer)inJason L Signor(Manager of the General Partner of Issuer)Lance M Hardenburg(Manager of the General Partner of Issuer)
Board seatCarl Soderstrom· per SEC Form D · $3.4M raise · filed Jul 2017
Access Vascular develops thrombus-evading intravascular catheters made from a proprietary biomaterial, offering an FDA-cleared PICC and the HydroMID peripherally inserted midline catheter to reduce vascular access complications.
BiotechHealthtechMedical DevicesNew MaterialsBedford, US
James Biggins(Chief Executive Officer, President and Founder)Dennis Byrne(Chief Commercial Officer)Scott Blood(VP of Regulatory and Quality)Katie Motherway(VP of Human Resources)Paul Sabin(Director)Joseph Pellegrino(Director)
Co-investorsTVM Capital Life ScienceTVM Capital
Accuryn develops an ICU monitoring system built around a Foley catheter that measures urine output, intra-abdominal pressure, and core body temperature to help clinicians detect conditions such as acute kidney injury and reduce catheter-associated urinary tract infections.
HardwareHealthtechMedical Devices
Austin, US
Mark S. Wochner(Executive Officer, Director)Laurence Walker(Director)Mark Wochner(Executive Officer, Director, Promoter)
BoardJR Garcia(Director)inRina Hartline(Director)John Paulos(Director)
Co-investorsCentral Texas Angel Network
Co-investorsHealth Wildcatters
Avantar provides property tax research and homeowner association (HOA) data services, including tax status, payment history, tax certificates, liens, exemptions verification, and HOA identification and document acquisition.
FintechPropTech
Co-investorsNaples Technology Ventures
Barricade Therapeutics is a clinical-stage oncology company developing BT-1501, an investigational once-daily oral small-molecule EBP inhibitor built on its TASIN platform to target genetic drivers of colorectal cancer.
BiotechHealthtechFort Worth, US
Neil Thapar(Chief Executive Officer)Neil C. Thapar(Co-Founder, Board Chairman, CEO & Chief Scientific Officer)John Walling(Co-Founder, SVP, CMC)Mariam E. Morris(Chief Operating Officer)Scott Jordan(Chief Financial Officer)
Betaliq is a clinical-stage pharmaceutical company developing topical eye-drop therapies for glaucoma using a licensed water-free drug delivery platform (EyeSol).
BiotechHealthtechMedical DevicesTarpon Springs, US
Oliver Schlueter(Executive Officer, Director)Barry Butler(Founder & Chief Executive Officer)Oliver Schluter(Executive Officer, Director)Oliver Schlüter(Chief Financial Officer)Ronil Patel(Chief Operating Officer)Haley Lemon(Executive Officer)
Co-investorsEvolution VC Partners
HealthtechBothell, US
Stephen Morse(Executive Officer, Director)Caitlin Morse(Executive Officer, Director, Promoter)
BoardAndrew Chomer(Director)
Co-investorsIn-Q-Tel
Cariloop provides digital and human-centered support services to relieve stress and anxiety experienced by family caregivers.
Enterprise SoftwareHealthtechHR TechImpact & Social GoodSaaSDallas, US
Michael Walsh(Co-Founder, Chief Executive Officer, and Board Chair)inSteven Theesfeld(Executive Officer, Director)
BoardMichael Stoltz(Director)
Co-investors1843 CapitalABS Capital PartnersHealth WildcattersKCRise FundNoro-Moseley PartnersRise of the Rest Seed
Carpe makes over-the-counter antiperspirant and sweatcare products, including deodorants and lotions, aimed at consumers dealing with excessive sweating and body odor.
ConsumerDirect to ConsumerWellness & Fitness
Co-investors7BC Venture CapitalDuke Capital PartnersIrishAngelsOval Park Capital
HealthtechEmeryville, US
Daniel Burnett(Director)Ulric Cote(Executive Officer, Director)Carter Meyer(Director)Bill Malecki(Executive Officer)
BoardDr. Jason Hong(Director)Anthony Natale(Director)in
Co-investorsAPERTURE Venture PartnersScientific Health DevelopmentThird Point VenturesLongwood FundVHM
Corvion develops a fully implanted left ventricular assist device (LVAD) for patients with severe heart failure, featuring a high-efficiency magnetically levitated pump, a small implantable battery/controller, and wireless charging.
HardwareHealthtechMedical Devices
Co-investorsD3VC
CounterFind provides AI-enhanced brand protection software and services that detect and remove counterfeit listings, fraudulent websites, and infringing content across marketplaces, social media, and the web.
AI & Machine LearningCybersecurityLegalTechSaaSFrisco, US
Darren Woodson(Co-founder & Chairman)Jamie Gerson(Co-founder / Head of Strategic Partnerships & Infringement Recovery)Rachel Aronson(Co-founder / Head of Business Development & Marketing)Don Adam(CEO)Michael DeCoursey(Executive Officer, Director)Robert Wechsler(Director)
Dignitana is a Swedish medical technology company that produces the DigniCap Scalp Cooling System, an FDA-cleared cooling device that helps chemotherapy patients minimize hair loss.
HardwareHealthtechMedical DevicesLund, SE
Co-investorsThe Perkins FundDolby Family Ventures
BiotechDraper, US
Fraser Bullock(Director)Jeffrey Williams(Executive Officer, Director)Martin Wensley(Executive Officer)Christopher B Munday(Director)Michael Hufford(Executive Officer, Director)Richard Brenner(Director)
EarthView develops BluBird, a continuous emissions monitoring system that detects, locates, and quantifies gas leaks in real time.
CleantechClimate TechDeep TechEnergyHardwareDallas, US
Bear Givhan(Co-founder & CEO)Jim Maslanik(Co-founder & Chief Scientist)John Reed(Executive Officer, Director)Frederick Bear Givhan(Executive Officer, Director)Kevin Yoon(VP of Product)
BiotechOmaha, US
Danial Burnett(Director)Carter Meyer(Director)Evan Luxon(Director)Deepak Gangahar(Director)Alan Chesler(Director)
Genomenon uses AI to read biomedical literature and expert scientists to curate variant- and patient-level genomic evidence, delivering regulatory-grade real-world evidence.
AI & Machine LearningBiotechDigital HealthAnn Arbor, US
Mark Kiel(Executive Officer, Director)Eli Salembier(Executive Officer, Director)Sam Globus(Executive Officer)inDr. Sam Globus(Chief Operating Officer)Michael Klein(Executive Officer, Director)David Gregorka(Director)
Co-investorsBeringeaID VenturesInvest MichiganIrishAngelsMarram VenturesMichigan Rise+1 more
GlycosBio conducts research and development using engineered lipid technologies to improve the bioavailability and therapeutic performance of natural bioactive molecules, including approaches targeting the intestinal, pulmonary, and skin microbiota.
BiotechDeep TechHealthtechHouston, US
Richard C. Jr. Cilento(Executive Officer, Director)
BoardDan Watkins(Director)Frank Foster(Director)inJoseph Walowski(Director)Victoria Niklas(Director)
Co-investorsGideon Hixon FundTexas HALO Fund
BiotechDallas, US
Lauren Tyra(Executive Officer, Director)Tobias Zutz(Executive Officer, Director)
BoardMichael Partsch(Director)Sundaresh Brahmasandra(Director)Steven Weinstein(Director)Gilbert G Garcia(Director)
Co-investorsFirst Round Capital
Co-investorsHealth Wildcatters
Hypergiant develops AI-enabled software platforms that process data and deliver actionable intelligence for rapid decision-making, serving Fortune 500 companies and government agencies.
AI & Machine LearningData & InfrastructureDefense TechEnterprise SoftwareAustin, US
Ben Lamm
Co-investorsPerot Jain
Iterion Therapeutics is a clinical-stage biopharmaceutical company developing cancer therapies targeting the Wnt/β-catenin pathway.
BiotechHealthtech
Rahul Aras(Chief Executive Officer)Ovid Trifan(Chief Medical Officer)inSteve Horrigan(Chief Scientific Officer)in
Co-investorsLumira VenturesPortal Innovations
LimiFlex develops the Dynamic Sagittal Tether, a spinal implant that stabilizes the lumbar spine after surgical decompression while preserving natural motion, positioned as an alternative to spinal fusion.
HardwareHealthtechMedical DevicesSan Carlos, US
Louie Fielding(Founder)
Co-investorsScientific Health Development
MAUI Imaging develops an advanced ultrasound imaging system, the K3900, that can see through and around barriers such as bone, air, and metal for use in trauma and interventional medicine.
Deep TechHealthtechMedical DevicesTucson, US
David Specht(Executive Officer, Director)Donald F Specht(Director)
BoardLevi Moore(Director)John Miller(Director)Alexandra M. Lopez(Director)Said Bolorforosh(Director)
MetaSaaS, now part of Flexera, provides a SaaS management platform that discovers, analyzes, and optimizes SaaS and AI applications across an organization, including shadow IT.
Cloud ComputingEnterprise SoftwareFintechSaaSAustin, US
Arlo Gilbert(Executive Officer, Director)Scott Hertel(Director)
Co-investorsChicago Ventures
Mission Bio develops single-cell biology tools and platforms for researchers and clinicians to enable precision medicine discovery and cancer treatment.
BiotechDeep TechDigital HealthMedical DevicesSouth San Francisco, US
Adam Sciambi(Founder)inPaul Billings, M.D., Ph.D.(Director)Urshit Parikh(Director)Charles Silver(Chief Executive Officer, Treasurer, Secretary and Director)Maneesh Jain, Ph.D.(Director)Adam Abate, Ph.D.(Director)
Co-investorsCota CapitalFusionKeiretsu ForumMighty CapitalFoothill Ventures
Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment.
HealthtechMedical Devices
Co-investorsOUP (Osage University Partners)US Venture Partners
Noninvasix develops a patented optoacoustic platform that non-invasively and continuously measures central venous oxygen saturation to help ICU clinicians diagnose and monitor tissue hypoxia in sepsis and septic shock patients in real time.
Digital HealthHardwareHealthtechMedical Devices
David J. Giarracco(Chief Executive Officer)Donald Prough(Clinical Vice President)
Co-investorsHealth WildcattersRockies Venture ClubTexas VenturesTMC Venture Fund
NovaScan develops MarginScan, a compact device combining spectral bioimpedance and AI/ML to detect and localize cancer at the margins of surgical excisions in seconds, for use by surgeons in cancer procedures.
AI & Machine LearningHealthtechMedical Devices
Co-investorsDipalo VenturesPortal Innovations
OncoNano is a clinical-stage oncology company developing cancer therapeutics based on its ON-BOARD polymeric micelle nanotechnology platform, which targets universal tumor markers to deliver anti-tumor payloads to the tumor microenvironment.
BiotechHealthtechDallas, US
Melissa Paoloni(Executive Officer)Matthew Head(Executive Officer)Kartik Krishnan(Executive Officer, Director)Joydeep Goswami(Director)Paritosh Dhawale(Director)Alvaro Guillem(Director)
OneDay creates interactive video pages and automated video campaigns powered by AI.
Marketing TechSaaS
Co-investorsSilverton PartnersVolition Capital
PerioSciences makes antioxidant-based oral and dental care products, including rinses and mists for dry mouth and gum health.
ConsumerDirect to ConsumerWellness & Fitness
symplr Directory centralizes and governs provider data into a single, deduplicated system of truth for health plans and health systems, supporting compliance with CMS, NCQA, HIPAA, and No Surprises Act requirements.
Digital HealthHealthtechSaaS
Co-investorsRex Health VenturesBessemer Venture PartnersWellington Management
Prolocor is developing diagnostic tests related to atherosclerotic cardiovascular disease and thrombotic risk, including platelet FcγRIIa-based assessment of risk in cancer patients.
BiotechDigital HealthHealthtechMedical DevicesPhiladelphia, US
Peter M. DiBattiste(Co-founder & CEO)inDavid Schneider(Executive Officer, Director)David J. Schneider(Co-founder & CSO)in
Proscia provides a digital pathology software platform that converts glass microscope slides into high-resolution digital images for viewing, management, and analysis by pathologists and research teams.
AI & Machine LearningBiotechHealthtechMedical DevicesPhiladelphia, US
David West, Jr.(Executive Officer, Director)David West(Executive Officer, Director)inDavid West, Sr.(Executive Officer, Director)
BoardAlex Niehenke(Director)inTom Loftus(Director)Robert Epstein(Director)
Co-investorsAlpha Intelligence CapitalEmerald Development ManagersFlybridge Capital PartnersFusionHitachi VenturesMaryland TEDCO+8 more
Radformation develops automation software for radiation oncology, including tools for deep-learning contouring, treatment planning, plan evaluation, independent calculations, treatment monitoring, billing QA, and machine QA.
AI & Machine LearningHealthtechMedical DevicesSaaSNew York, US
Kurt Sysock(Executive Officer, Director, Promoter)Kurt S(Co-Founder & CEO)Alan N(CTO, Co-founder)Liz V(Co-founder & CXO)Karl O(CSO)
Co-investorsTexas VenturesThe Fund
Alto operates a vertically integrated electric rideshare fleet in the US, running vehicles and W-2 drivers on the Uber platform (Uber Black, Uber XL, UberTeen) while building depot, charging, maintenance, and fleet management infrastructure to support autonomous vehicle operations.
CleantechLogistics & Supply ChainMobility & Transportation
Co-investorsUberCrunchFundEscalate Capital PartnersRoad VenturesTuesday Capital
Semler Scientific develops portable, point-of-care diagnostic technology that helps healthcare providers detect early signs of chronic diseases such as peripheral arterial disease (PAD).
Digital HealthHealthtechMedical Devices
Stingray Therapeutics develops Vizenpistat (SR-8541A), an ENPP1 inhibitor that blocks the ENPP1 innate immune checkpoint to reactivate the cGAS-STING pathway against cancer.
BiotechHealthtech
Supergoop! is a suncare brand that develops SPF sunscreen products, including formulas for the whole family across different skin tones and activities.
ConsumerDirect to ConsumerWellness & Fitness
Co-investorsElizabeth Street VenturesGrace Beauty CapitalSWAT Equity PartnersTq Ventures Llc
Take Command provides HRA (Health Reimbursement Arrangement) administration software, including ICHRA management, that lets employers offer individual health insurance coverage to their workforce.
HealthtechHR TechInsurTech
Co-investorsSJF Ventures
Telperian provides AI- and biostatistics-driven software and services for clinical trial design and delivery, including analytics-first trial planning and simulation (Data Design & Intelligence) plus dashboards and FDA submission-ready deliverables (Tech-Enabled Services).
AI & Machine LearningBiotechDigital Health
TheraNova is a venture studio and incubator that develops medical devices from concept through clinical trials, regulation, and commercialization using a shared R&D model.
BiotechHealthtechMedical DevicesSan Francisco, US
Validic operates a health IoT platform that connects over 700 medical devices and health apps to health systems, health plans, and life sciences organizations for clinical use.
Data & InfrastructureDigital HealthHealthtechIoT
Drew Schiller(Founder)in
Co-investorsKaiser Permanente VenturesNTT DOCOMO VenturesSJF VenturesTech WildcattersBIP Capital
WorkShield offers a workplace misconduct management platform that helps organizations identify, track, and address the hidden costs of workplace misconduct.
Future of WorkHR TechSaaS
Worlds develops AI technology for processing and analyzing visual data in spatial and temporal context to enable enterprise applications in the physical world.
Advanced ManufacturingAI & Machine LearningDeep TechEnterprise Software
Dave Copps(CEO)Chris Rhode(President)
Co-investorsMoneta VenturesPiva CapitalPerot JainPETRONAS Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 4
IPOs and acquisitions across the tracked portfolioLantern PharmaNASDAQ: LTRNSavaraNASDAQ: SVRAPhyndacq. by symplrValidicacq. by ChartSpan
Portfolio news
latest coverage across their companies
NovaScan · proactiveinvestors.com · Aug 20, 2026
Validic · dailyaibrief.com · Jun 30, 2026
Channel Medsystems · trysignalbase.com · Mar 25, 2026
Barricade Therapeutics · kingscrowd.com · Mar 3, 2026
Proscia · insightpartners.com · Feb 19, 2026
Genomenon · investmichigan.org · Nov 20, 2025
Frequently asked questions
- How many investments has Green Park & Golf Ventures made?
- Green Park & Golf Ventures has 56 tracked investments, 2 of which have exited via acquisition or IPO, including 3 dated in the last 24 months.
- What stage does Green Park & Golf Ventures invest at?
- Green Park & Golf Ventures invests at the Pre-Seed, Seed, Series A, Series B, Growth stages.
- What is Green Park & Golf Ventures's typical check size?
- Green Park & Golf Ventures typically writes checks of $500K – $2M.
- What sectors does Green Park & Golf Ventures focus on?
- Green Park & Golf Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Green Park & Golf Ventures located?
- Green Park & Golf Ventures is headquartered in Dallas, US.
- Who does Green Park & Golf Ventures co-invest with?
- Green Park & Golf Ventures most often shares deals with Health Wildcatters, Fusion, IrishAngels, among 68 tracked co-investors.
Co-investors · 1
What If Ventures is a venture capital firm investing in transformative technology, with a focus on healthcare/mental health and defense technology.
Firms observed investing alongside Green Park & Golf Ventures, from public investor directories. Shared companies are the overlap with Green Park & Golf Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Panacea Venture is a global investment firm, spun out from Kleiner Perkins, focused on life sciences and healthcare innovation. It invests across geographies and stages, from company formation through expansion and public markets.
Accelmed Partners is a healthcare technology investment firm that applies a private equity approach to a sector traditionally served by venture and early-stage growth investors, focusing on tools & diagnostics, digital health, and tech-enabled services.